Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): Pilot Study

Study acronym: FIND-AF
StatusActive, Not Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion pushed from Feb 28, 2026 to Feb 28, 2033
    • Eligibility criteria expanded, about 7 words
    • Publications: details revised at 2 of 2 entries
  2. Primary completion date changed from estimate of Jun 2025 to Jun 16, 2025
    • Study completion date: Feb 2026 to Feb 28, 2026
    v5
  3. Primary completion date: Oct 2024 to Jun 2025
    • Trial status: Enrolling by Invitation to Active, Not Recruiting
    • Study completion date: Feb 2025 to Feb 2026
    v4
  4. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Jul 2023 to Oct 1, 2023
    v3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Leeds
35 trials monitored
See 1 trial at risk
Heart Disease
8,814 trials monitored
See 428 trials at risk
Stroke
3,537 trials monitored
See 161 trials at risk
Atrial Fibrillation
1,188 trials monitored
See 57 trials at risk
The purpose of this study is to trial a new intervention - risk-guided AF screening using an EHR-based risk score and remote ECG monitoring process - and to characterise individuals at elevated predicted AF risk.
Trial Details
NCT Number NCT05898165
Lead Sponsor University of Leeds
Collaborators: British Heart Foundation, Daiichi Sankyo, The Leeds Teaching Hospitals NHS Trust
Conditions
(from sponsor)		 Atrial Fibrillation, Heart Diseases, Cardiovascular Diseases
Related terms Atrial Fibrillation, Cardiovascular Diseases, Heart Diseases, Stroke
Enrollment 1,955 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov